Best Healthcare Companies in Cambridge, United Kingdom
The 80 best Healthcare companies in Cambridge, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AstraZeneca.
Ranked: Best Healthcare companies in Cambridge
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | AstraZeneca Developer of pharmaceutical medicines for oncology and various chronic diseases | $4.1B | 11 mo ago | 83,100 | Pascal Soirot CEO | Adobe Experience ManagerApple iCloud MailJava+22 | 2,817 patents Antibody therapeutics and antibody‑drug conjugates for oncology and infectious diseases | — |
| 2 | Kymab Provider of monoclonal antibody therapeutics for multiple diseases | $348M | 84 mo ago | 183 | Allan Bradley Founder & Director | — | 872 patents Immunotherapy antibodies targeting immune checkpoints and co‑stimulatory receptors | — |
| 3 | Abzena Provider of antibody discovery, cell line development, and bio analytics services | $69M | 50 mo ago | 306 306 → 444 (+45%) · sector median +24% | Jonathan Goldman CEO | WordPressApple iCloud MailMicrosoft 365+34 | 9 patents Therapeutic antibody-drug conjugates targeting PSMA for cancer treatment | — |
| 4 | Mosaic Therapeutics Developer of targeted cancer combination therapies | $28M | 38 mo ago | 21 | Mathew Garnett Co-Founder | WordPressMySQLPHP+17 | — | — |
| 5 | Medovate Developer of anaesthesia care devices | $12M | 102 mo ago | 17 | — | WordPressMySQLPHP+21 | 22 patents Advanced fluid delivery/withdrawal systems and negative‑pressure wound therapy devices | — |
| 6 | Enhanc3D Genomics Medical research lab focused on conducting genome sequencing studies | $11M | 44 mo ago | 12 12 → 15 (+25%) · sector median +24% | Peter Fraser Co-Founder | WordPressMySQLPHP+12 | — | — |
| 7 | Wellcome Genome Campus Labs conducting research on genomics & biodata business | $10M | 55 mo ago | — | Mike Stratton CEO | WordPressMySQLPHP+14 | — | 1 partnership · 2 expansions |
| 8 | Tristel Infection control products for surfaces and instruments | $9M | 95 mo ago | 199 199 → 164 (-18%) · sector median +24% | Paul Swinney CEO & Director | WordPressApple iCloud MailMicrosoft 365+24 | 398 patents Patents concentrated in health & consumer products | — |
| 9 | Metrion Biosciences CRO specializing in ion channel screening, cardiac safety profiling and drug discovery services | $8M | 30 mo ago | 48 | — | WordPressPleskMySQL+22 | 13 patents Design and synthesis of heterocyclic sulfonamide small‑molecule therapeutics | 1 job opening · 1 expansion |
| 10 | PillSorted Distributor of drugs | $6M | 49 mo ago | 12 12 → 25 (+108%) · sector median +24% | Mohammad Mohaghegh Co-Founder | Cart FunctionalityWooCommerceWordPress+33 | — | 3 job openings |
| 11 | Bourn Hall Clinic Provider of fertility treatments, testing, preservation, and donor assisted reproduction | $6M | 65 mo ago | 106 | Mike Macnamee CEO | WordPressMySQLPHP+27 | — | 3 job openings |
| 12 | Domainex Drug discovery CRO company for epigenetic research and inflammatory diseases | $5M | 121 mo ago | 93 93 → 87 (-6%) · sector median +24% | — | DrupalPHPReact+13 | 35 patents Selective small-molecule inhibitors of IKKE, TBK1, and SIK2 kinases for therapeutic use. | — |
| 13 | IONTAS Provider of therapeutic antibody discovery and development services | $3M | 96 mo ago | — | Peter S Co-Founder & CTO | — | 61 patents Eukaryotic cell display platforms for bispecific antibody and protein variant engineering | — |
| 14 | EDX Medical Group Research laboratory focused on medical diagnostics solutions | $2M | 37 mo ago | 7 | Chris Evans Founder | WordPress Block EditorBricksWordPress+22 | — | — |
| 15 | DeepMirror Provider of drug research & development, data analysis, and imaging services | $2M | 22 mo ago | 9 | Ryan Greenhalgh Co-Founder and CTO | WebflowGSAPPlausible+18 | — | 1 partnership |
| 16 | Creasallis Provider of novel protein engineering solutions for antibody-based therapeutics | $1M | 43 mo ago | 2 | — | GoDaddy Website BuilderReactRequireJS+9 | 9 patents Peptide-based therapeutic agents and immunomodulatory compositions. | — |
| 17 | Lab21 Personalised medicine diagnostic specialist | $838K | 187 mo ago | 15 | Graham Mullis Co-Founder | — | — | — |
| 18 | Antwerp Dental Group Chain of dental clinics | $680K | 73 mo ago | — | Raj Wadhwani Founder & Owner | — | — | — |
| 19 | Five Alarm Bio Provider of healthcare technology services | $597K | 39 mo ago | 4 | Janette Thomas CEO | — | — | — |
| 20 | Atlas Medical In vitro diagnostic reagents and kits | $270K | 101 mo ago | — | Raed Shadfan Managing Director | WordPressMySQLPHP+23 | — | — |
| 21 | Cambridge Protein Arrays Developer of DNA microarray to protein microarray(DAPA) platform | $120K | 113 mo ago | 2 | — | — | — | — |
| 22 | Costello Medical Provider of medical affair, market access, statistics, and other consulting services for biopharma sector | $101K | 219 mo ago | — | — | WordPressApple iCloud MailMicrosoft 365+20 | — | 1 award |
Top 12 Healthcare companies in Cambridge
#1
Public · Cambridge, England · founded 1999 · 83100 employees$4.1Braised▾
Developer of pharmaceutical medicines for oncology and various chronic diseases. Research activities focus on the discovery and production of therapeutics targeting cancer, cardiovascular conditions, renal disorders, metabolic diseases, respiratory ailments, and immunological conditions. The business also develops treatments for rare diseases and infectious conditions. Operations involve clinical trials and the application of data science to identify new molecular entities for medical use.
- Jul 2025Grant (prize money)$6.1M
- Dec 2021Post IPO$6.1M
- May 2021Grant (prize money)$334.2K
- Jan 2021Grant (prize money)$371.8K
#2
Seed · Cambridge, England · founded 2019 · 9 employees$1.9Mraised▾
Provider of drug research & development, data analysis, and imaging services
- Aug 2024Seed$1.1M
- Aug 2022Seed$538.7K
- Jul 2021Seed$208.5K
#3
Series B · Cambridge, England · founded 2015 · 48 employees$8.4Mraised▾
Metrion is a CRO specializing in ion channel screening, cardiac safety profiling and drug discovery services on a fee-for-service or collaboration basis. They offer services such as ion channel screening, cardiac safety panel screening (CiPA and hERG), neuroscience panels (neuroscience-related ion channel screening assays and platforms) and translational assays (phenotypic assays to aid the translation of in vitro cardiac safety and neuroscience data to the preclinical stage). They claim to have over 80 years of combined global ion channel research and drug discovery expertise and also in a wide range of ion channel gene families (Nav, Cav, Kv, hERG, TRP, GluR, nAChR), pain pharmacology, and synaptic transmission and plasticity. The company was formed by a management buyout from Xention Ltd., in October 2015.
- Dec 2023Series B$4.7M
- Apr 2021Seed$3.7M
- Mar 2019Seed—
- Aug 2018Grant (prize money)$819.7K
#4
Acquired · Cambridge, England · founded 2009 · 183 employees$348Mraised▾
Kymab develops monoclonal antibody therapeutics for oncology and other disorders. Its proprietary KyMouse platform allows for the precise production of a diverse range of fully-humanized monoclonal antibodies. It has three preclinical programs for oncology and several discovery stage programs for other indications.
- Jun 2019Series C$10M
- Mar 2019Series C$68.1M
- Jul 2017Series C$49.9M
- Jan 2017Grant (prize money)$9M
#5
Acquired · Cambridge, England · founded 2001 · 306 employees$69.4Mraised▾
Provider of antibody discovery, cell line development, and bio analytics services. The company mainly provides proprietary technologies, mammalian and bio conjugates manufacturing, peptide synthesis, analytical development, cell line development, and bio assays services.
- Mar 2022Post IPO$65M
- Jul 2020Post IPO$10M
- Apr 2017Post IPO$3.7M
- Apr 2017Post IPO$31.1M
#6
Series A · Cambridge, England · founded 2020 · 21 employees$28Mraised▾
Developer of targeted cancer combination therapies. It uses a unique combination of computational and experimental biology to discover and develop these therapies. The company focuses on biomarker-defined settings where significant unmet medical needs exist. Its approach involves identifying novel drug combinations and stratification biomarkers through large-scale data analysis and in-vitro testing. This allows for more effective and less toxic treatments by moving away from a "one-size-fits-all" approach to cancer treatment. The company leverages expertise in genomics, cancer cell biology, and clinical development to accelerate the development and delivery of new medicines.
- Apr 2023Series A$28M
#7
Series A · Cambridge, England · founded 2020 · 12 employees$11.3Mraised▾
Medical research lab focused on conducting genome sequencing studies
- Oct 2022Series A$11.3M
#8
Funding Raised · Cambridge, England · founded 1994$9.5Mraised▾
Labs conducting research on genomics & biodata business
- Nov 2021Grant (prize money)$256.9K
- Jun 2021Grant (prize money)$258.2K
- Feb 2021Grant (prize money)$257.4K
- Nov 2020Grant (prize money)$266K
#9
Public · Cambridge, England · founded 2022 · 7 employees$2.1Mraised▾
Research laboratory focused on medical diagnostics solutions
- Apr 2023Seed$2.1M
#10
Seed · Cambridge, England · founded 2019 · 12 employees$6Mraised▾
Distributor of drugs
- Apr 2022Seed$6M
#11
Seed · Cambridge, England · founded 2021 · 2 employees$1Mraised▾
Provider of novel protein engineering solutions intended to enhance efficacy, and safety, and lower the cost of goods for antibody-based drugs. The company specializes in biotechnology services like antibody engineering, cancer therapy, monoclonal antibodies, bispecific antibodies, and more, enabling the biopharmaceutical industry to implement engineering solutions for antibody bottlenecks.
- Nov 2022Seed$513K
- Sep 2022Seed$496.8K
#12
Early Stage · Cambridge, England · founded 1980 · 106 employees$5.8Mraised▾
Provider of fertility treatments, testing, preservation, and donor assisted reproduction. It offers services for heterosexual couples, same-sex couples, and single individuals seeking to conceive. Treatments include IVF, ICSI, IUI, frozen embryo transfer, and ovulation induction. Genetic testing and fertility preservation options such as egg and sperm freezing are available. The organization also provides donor egg and sperm programs, as well as surrogacy support.
- Jan 2021Unattributed—
- Feb 2014Unattributed$5.8M
- Jul 2010Unattributed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.